R-DA-EPOCH improves the outcome over that of the R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high IPI, but not for double expressor lymphoma
Xu, W., Zhang, X., Liang, J., Wang, L., Zhu, H., Wu, W., Fan, L., Li, J.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_82
Date:
June, 2017
File:
PDF, 249 KB
english, 2017